Daito Pharmaceutical Co., Ltd.'s total assets for Q2 2024 were ¥79.63B, a decrease of -2.80% from the previous quarter. JP:4577 total liabilities were ¥27.61B for the fiscal quarter, a -7.48% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.